Doron Schwartz

8.2k total citations · 4 hit papers
155 papers, 4.8k citations indexed

About

Doron Schwartz is a scholar working on Nephrology, Hematology and Physiology. According to data from OpenAlex, Doron Schwartz has authored 155 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Nephrology, 33 papers in Hematology and 33 papers in Physiology. Recurrent topics in Doron Schwartz's work include Inflammatory Bowel Disease (32 papers), Erythropoietin and Anemia Treatment (31 papers) and Nitric Oxide and Endothelin Effects (27 papers). Doron Schwartz is often cited by papers focused on Inflammatory Bowel Disease (32 papers), Erythropoietin and Anemia Treatment (31 papers) and Nitric Oxide and Endothelin Effects (27 papers). Doron Schwartz collaborates with scholars based in Israel, United States and United Kingdom. Doron Schwartz's co-authors include Donald S. Silverberg, Adrian Iaina, Dov Wexler, Miriam Blum, Idit F. Schwartz, David S. Sheps, Gad Keren, Shoshana Steinbruch, Roland C. Blantz and Itzhak Shapira and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

Doron Schwartz

151 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

2000 563 citations Donald S. Silverberg, Doron Schwartz et al. profile →
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study

2001 501 citations Donald S. Silverberg, Doron Schwartz et al. profile →
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus

2021 242 citations Ayelet Grupper, Doron Schwartz et al. profile →
Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis

2021 224 citations Ayelet Grupper, Nechama Sharon et al. Clinical Journal of the American Society of Nephrology profile →

Peers

Doron Schwartz

HEMAT

CCM

NEPHR

PHYSI

Kerttu Irjala Finland

Arintaya Phrommintikul Thailand

Ciro Esposito Italy

Sydney Tang Hong Kong

Niels Graudal Denmark

Andreas Kribben Germany

Samuel N. Heyman Israel

Bernhard M. W. Schmidt Germany

Hiromichi Suzuki Japan

Juan Carlos Ruiz Spain

Kerttu Irjala Finland

Doron Schwartz

1.5k ×0.9

HEMAT

629 ×0.5

CCM

264 ×0.3

NEPHR

819 ×1.2

PHYSI

531 ×0.9

Citations per year, relative to Doron Schwartz Doron Schwartz (= 1×) peers Kerttu Irjala

Countries citing papers authored by Doron Schwartz

Since Specialization

Citations

This map shows the geographic impact of Doron Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doron Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doron Schwartz more than expected).

Fields of papers citing papers by Doron Schwartz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doron Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doron Schwartz. The network helps show where Doron Schwartz may publish in the future.

Co-authorship network of co-authors of Doron Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Doron Schwartz. A scholar is included among the top collaborators of Doron Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doron Schwartz. Doron Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schwartz, Doron, Michael Friger, Ruslan Sergienko, et al.. (2025). Gender Differences in Coping Strategies and Life Satisfaction Following Cognitive-Behavioral and Mindfulness-Based Intervention for Crohn’s Disease: A Randomized Controlled Trial. Journal of Clinical Medicine. 14(5). 1569–1569. 1 indexed citations

Grupper, Ayelet, et al.. (2025). Long-term efficacy of Rituximab in steroid dependent and frequent relapsing adult nephrotic syndrome. BMC Nephrology. 26(1). 126–126.

Motro, Yair, Anna Nemirovsky, Doron Schwartz, et al.. (2024). Cognitive behavioral and mindfulness with daily exercise intervention is associated with changes in intestinal microbial taxa and systemic inflammation in patients with Crohn’s disease. Gut Microbes. 16(1). 2337269–2337269. 9 indexed citations

Anbar, Ronit, et al.. (2024). Assessment of the Correlation Between Serum Phosphate Level and Muscle Strength as Measured by Handgrip Strength in Patients Treated With Hemodialysis. Canadian Journal of Kidney Health and Disease. 11. 1045222363–1045222363. 2 indexed citations

Baruch, Roni, Doron Schwartz, Idit F. Schwartz, et al.. (2023). The Long-Term Outcome of Kidney Transplant Recipients in the Eighth Decade Compared With Recipients in the Seventh Decade of Life. Transplantation Proceedings. 55(9). 2063–2070. 2 indexed citations

Abu‐Freha, Naim, et al.. (2023). Ethnic Issues and Disparities in Inflammatory Bowel Diseases: What Can We Learn from the Arab Population in Israel?. Journal of Personalized Medicine. 13(6). 1008–1008. 4 indexed citations

Ledder, Oren, Esther Orlanski‐Meyer, Yiska Loewenberg Weisband, et al.. (2023). Residence in Peripheral Regions and Low Socioeconomic Status Are Associated With Worse Outcomes of Inflammatory Bowel Diseases: A Nationwide Study From the epi-IIRN. Inflammatory Bowel Diseases. 30(1). 1–8. 3 indexed citations

Regev, Shirley, Doron Schwartz, Orly Sarid, et al.. (2023). Randomised clinical trial: Psychological intervention improves work productivity and daily activity by reducing abdominal pain and fatigue in Crohn's disease. Alimentary Pharmacology & Therapeutics. 57(8). 861–871. 9 indexed citations

Grupper, Ayelet, Doron Schwartz, Idit F. Schwartz, et al.. (2022). Nonalcoholic Fatty Liver Disease before Kidney Transplantation Correlates with New Onset Diabetes and Poor Metabolic Outcomes. American Journal of Nephrology. 53(8-9). 636–645. 4 indexed citations

10.

Schwartz, Doron, Idit F. Schwartz, Yaacov Goykhman, et al.. (2022). Presence of Sarcopenia before Kidney Transplantation Is Associated with Poor Outcomes. American Journal of Nephrology. 53(6). 427–434. 19 indexed citations

11.

Regev, Shirley, Shmuel Odes, Vered Slonim‐Nevo, et al.. (2021). Normative data for the Brief Symptom Inventory for patients with Crohn's disease. Psychology and Health. 37(2). 246–257. 3 indexed citations

12.

Atia, Ohad, Esther Orlanski‐Meyer, Shira Greenfeld, et al.. (2021). Improved Outcomes of Paediatric and Adult Crohn’s Disease and Association With Emerging Use of Biologics–A Nationwide Study From the Epi-IIRN. Journal of Crohn s and Colitis. 16(5). 778–785. 19 indexed citations

13.

Atia, Ohad, Esther Orlanski‐Meyer, Shira Greenfeld, et al.. (2021). Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRN. Journal of Crohn s and Colitis. 16(5). 796–803. 30 indexed citations

14.

Grupper, Ayelet, Nechama Sharon, Talya Finn, et al.. (2021). Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis. Clinical Journal of the American Society of Nephrology. 16(7). 1037–1042. 224 indexed citations breakdown →

15.

Nemirovsky, Anna, Liel Cohen-Lavi, Doron Schwartz, et al.. (2021). Brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: Observations from a randomized controlled trial in patients with Crohn's disease. Brain Behavior & Immunity - Health. 19. 100407–100407. 19 indexed citations

16.

Grupper, Ayelet, Doron Schwartz, Shlomo Berliner, et al.. (2018). Normal-range albuminuria in healthy subjects increases over time in association with hypertension and metabolic outcomes. Journal of the American Society of Hypertension. 12(11). 759–767. 6 indexed citations

17.

Kopylov, Uri, Irit Avni‐Biron, Yulia Ron, et al.. (2018). Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease—The Israeli real world experience. Digestive and Liver Disease. 51(1). 68–74. 21 indexed citations

18.

Shapir, Nir, Doron Schwartz, Gil Chernin, et al.. (2015). Preclinical and Preliminary Clinical Evaluation of Genetically Transduced Dermal Tissue Implants for the Sustained Secretion of Erythropoietin and Interferon α. PubMed. 26(4). 216–227. 7 indexed citations

19.

Abu‐Freha, Naim, Doron Schwartz, Gil Ben Yakov, et al.. (2015). Inflammatory bowel disease among Bedouin Arabs in southern Israel. European Journal of Gastroenterology & Hepatology. 27(3). 230–234. 13 indexed citations

20.

Silverberg, Donald S., et al.. (2008). The Role of Correction of Anaemia in Patients with Congestive Heart Failure: A Short Review. European Journal of Heart Failure. 10(9). 819–823. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact